Skip to main content
  • 3 Studies Highlight Potential for Coronary Obstruction After TAVR

    Now that transcatheter aortic valve replacement (TAVR) is approved as treatment in all patients with severe, symptomatic aortic stenosis, feasibility of future access to the coronary arteries for selective angiography and PCI is receiving more attention.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details